Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Expanding Indications for the Human Papillomavirus Vaccine

Expanding Indications for the Human Papillomavirus Vaccine Opinion EDITORIAL FROM THE AMERICAN HEAD AND NECK SOCIETY One Small Step for the Prevention of Head and Neck Cancer, but One Giant Leap Remains Nosayaba Osazuwa-Peters, BDS, PhD, MPH, CHES; Evan M. Graboyes, MD, MPH; Samir S. Khariwala, MD, MS In the US, the incidence of human papillomavirus (HPV)– have focused our efforts primarily on diagnosis and treat- related oropharyngeal cancer (OPC) has been growing at an ment of HPV-related OPC while neglecting our concomitant 1-3 alarming rate for the past 4 decades. In 2011, HPV-related OPC public health duties. In so doing, we are missing a critical op- was predicted to surpass cervical cancer in annual incidence portunity to save lives, decrease morbidity, and practice cost- 2 10 in the US by 2020. However, because of the continued de- effective population health. This need not be the case any creasing incidence of cervical cancer and the accelerating in- longer. To help transform this small step for preventing HNC cidence of OPC, HPV-related OPC actually surpassed cervical into a giant leap, we offer the following 4 suggestions: cancer to become the most common HPV-related malignancy 1. Launch a public health campaign to provide education in the US in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Otolaryngology - Head & Neck Surgery American Medical Association

Expanding Indications for the Human Papillomavirus Vaccine

Loading next page...
 
/lp/american-medical-association/expanding-indications-for-the-human-papillomavirus-vaccine-U1e0j4Z50k
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2168-6181
eISSN
2168-619X
DOI
10.1001/jamaoto.2020.4068
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL FROM THE AMERICAN HEAD AND NECK SOCIETY One Small Step for the Prevention of Head and Neck Cancer, but One Giant Leap Remains Nosayaba Osazuwa-Peters, BDS, PhD, MPH, CHES; Evan M. Graboyes, MD, MPH; Samir S. Khariwala, MD, MS In the US, the incidence of human papillomavirus (HPV)– have focused our efforts primarily on diagnosis and treat- related oropharyngeal cancer (OPC) has been growing at an ment of HPV-related OPC while neglecting our concomitant 1-3 alarming rate for the past 4 decades. In 2011, HPV-related OPC public health duties. In so doing, we are missing a critical op- was predicted to surpass cervical cancer in annual incidence portunity to save lives, decrease morbidity, and practice cost- 2 10 in the US by 2020. However, because of the continued de- effective population health. This need not be the case any creasing incidence of cervical cancer and the accelerating in- longer. To help transform this small step for preventing HNC cidence of OPC, HPV-related OPC actually surpassed cervical into a giant leap, we offer the following 4 suggestions: cancer to become the most common HPV-related malignancy 1. Launch a public health campaign to provide education in the US in

Journal

JAMA Otolaryngology - Head & Neck SurgeryAmerican Medical Association

Published: Dec 5, 2020

References